Sientra, Inc.
- Jurisdiction
United States - ISIN
US82621J1051 (SIEN )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
3
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. Read full profile
Fundamentals
- Net revenue
€77.02M - Gross margin
42.1% - EBIT
-€43.95M - EBIT margin
-57.1% - Net income
-€50.78M - Net margin
-65.9%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Earnings Calls
Earnings Calls
Latest earnings call: November 9, 2023 (Q3 2023)